Adjuvant Radiotherapy of Sintilimab Versus TACE for HCC | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Adjuvant Radiotherapy of Sintilimab Versus TACE for HCC	Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm	Recruiting	Phase 3	2025-09-22		NCT07186621

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Beijing 302 Hospital	32
Beijing Ditan Hospital	26
Cancer Institute and Hospital, Chinese Academy of Medical Sciences	294
Eastern Hepatobiliary Surgery Hospital	22
Nanfang Hospital, Southern Medical University	248
Peking University People's Hospital	269

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cancer Institute and Hospital, Chinese Academy of Medical Sciences	Beijing	China	16